Back
Oruka Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
ORKA
Oruka Therapeutics, Inc.
Last Price:
$32.04
Seasonality Move:
-5.93%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.
Oruka Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.4 | Buy |
| 20-day SMA: | 30.23 | Buy |
| 50-day SMA: | 28.74 | Buy |
| 200-day SMA: | 17.1 | Buy |
| 8-day EMA: | 30.97 | Buy |
| 20-day EMA: | 30.17 | Buy |
| 50-day EMA: | 27.87 | Buy |
| 200-day EMA: | 21.26 | Buy |
Oruka Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.88 | Buy |
| Relative Strength Index (14 RSI): | 61.61 | Buy |
| Chaikin Money Flow: | 75283 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.54 - 31.42) | Buy |
| Bollinger Bands (100): | (16.23 - 29.29) | Buy |
Oruka Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oruka Therapeutics, Inc. Stock
Is Oruka Therapeutics, Inc. Stock a Buy?
-
Oruka Therapeutics, Inc. share price is 32.12 while ORKA 8-day simple moving average is 30.40, which is a Buy signal.
-
The stock price of ORKA is 32.12 while Oruka Therapeutics, Inc. 20-day SMA is 30.23, which makes it a Buy.
-
Oruka Therapeutics, Inc. 50-day simple moving average is 28.74 while ORKA share price is 32.12, making it a Buy technically.
-
ORKA stock price is 32.12 and Oruka Therapeutics, Inc. 200-day simple moving average is 17.10, creating a Buy signal.
ORKA Technical Analysis vs Fundamental Analysis
Sell
40
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy or a Sell?
-
Oruka Therapeutics, Inc. stock is rated a SellThe current Oruka Therapeutics, Inc. [ORKA] share price is $32.12. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Oruka Therapeutics, Inc. Stock Info
Market Cap:
1.6B
Price in USD:
32.12
Share Volume:
262K
Oruka Therapeutics, Inc. 52-Week Range
52-Week High:
32.64
52-Week Low:
5.49
Sell
40
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Oruka Therapeutics, Inc. Share Price Forecast
-
What is the Oruka Therapeutics, Inc. stock price today?The Oruka Therapeutics, Inc. stock price is 32.12 USD today.
-
Will ORKA stock go up or go down?Oruka Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Oruka Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oruka Therapeutics, Inc. is overvalued.
Is Oruka Therapeutics, Inc. Stock a Buy?
-
Oruka Therapeutics, Inc. share price is 32.12 while ORKA 8-day exponential moving average is 30.97, which is a Buy signal.
-
The stock price of ORKA is 32.12 while Oruka Therapeutics, Inc. 20-day EMA is 30.17, which makes it a Buy.
-
Oruka Therapeutics, Inc. 50-day exponential moving average is 27.87 while ORKA share price is 32.12, making it a Buy technically.
-
ORKA stock price is 32.12 and Oruka Therapeutics, Inc. 200-day simple moving average is 21.26, creating a Buy signal.
Fundamental Analysis of Oruka Therapeutics, Inc.
Is Oruka Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.
Technical Analysis of Oruka Therapeutics, Inc.
Should I short Oruka Therapeutics, Inc. stock?
-
ORKA Moving Average Covergence Divergence (MACD) indicator is 0.88, suggesting Oruka Therapeutics, Inc. is a Buy
-
Oruka Therapeutics, Inc. Relative Strength Index (RSI) is 61.61, which suggest Oruka Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Oruka Therapeutics, Inc. is (28.54 - 31.42), which suggest Oruka Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Oruka Therapeutics, Inc. is (16.23 - 29.29), which suggest Oruka Therapeutics, Inc. is a Buy
* Oruka Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.